Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
While Ipamorelin's human data is limited (primarily PK/PD studies and a discontinued Phase II for postoperative ileus), the dose-dependent acute stimulation aligns with 3-10 fold increases in peak GH, with effects lasting approximately 2-3 hours per administration (PMID: 10496658)
Using starting compositions with compounds rather than single elements is another strategy
Why it matters: One of the most promising molecules in aging science
Synergistic neuroprotective therapies with hypothermia
BioMed Research International , 2015, 648108.
Neither compound is FDA-approved for any indication our CJC-1295 Ipamorelin FDA status guide covers the regulatory details in full
